Stay updated on Clinical Trial: Nivolumab in HCC with Electroporation
Sign up to get notified when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.

Latest updates to the Clinical Trial: Nivolumab in HCC with Electroporation page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRevision: v3.3.4 is now displayed, replacing the previous Revision: v3.3.3.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedThe page footer now displays the revision notice 'Revision: v3.3.3'. References to 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' were removed.SummaryDifference0.1%

- Check58 days agoChange DetectedRevision notice updated from v3.2.0 to v3.3.2 on the page; this change does not affect the study content or trial data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check65 days agoChange DetectedThe government funding status notice banner on the page has been removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check79 days agoChange DetectedThe two screenshots show no additions or deletions to the study details; any differences are minor visual/layout adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check107 days agoChange DetectedVersion bumped to v3.2.0 with an added government-operating-status notice; the previous v3.1.0 deletion indicates the page now reflects the updated version.SummaryDifference3%

Stay in the know with updates to Clinical Trial: Nivolumab in HCC with Electroporation
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Nivolumab in HCC with Electroporation page.